Health Care/Hospital

IRBM Expands Global Reach in Drug Discovery with New Boston Office

Strategic Growth and Increased Visibility Set to Enhance IRBM's Leadership Position ROME, March 5, 2024 /PRNewswire/ -- IRBM, an integrated drug discovery Contract Research Organization (CRO), announces its global expansion with a new office inBoston, Massachusetts, a cornerstone for biotechnolo...

2024-03-05 20:24 1459

One Million Global Healthcare Seekers Embrace MedicalTourism.com: Medical Tourism Magazine Leads the Way

WEST PALM BEACH, Fla., March 5, 2024 /PRNewswire/ -- Launched in 2023 by The Medical Tourism Association, DarwinAI (Artificial Intelligence) is an AI-enabled marketing technology revolutionizing the medical tourism landscape. Darwin AI uses powerful AI-enabled algorithms to drive brand awareness,...

2024-03-05 16:00 1221

Cetaphil® Strengthens Ties with the Malaysian Community through Collaborative Partnership with Mira Filzah as the New Face of the Brand in 2024

KUALA LUMPUR, Malaysia, March 5, 2024 /PRNewswire/ -- Cetaphil®, the No.1 dermatological skincare brand inMalaysia, proudly announces a significant partnership in anticipating of the holy month of Ramadan. The brand is thrilled to unveil the newest face of Cetaphil® for 2024, the versatile Malays...

2024-03-05 14:58 1257

Innovent and AnHeart Therapeutics Announce the NMPA of China Has Accepted Second NDA for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer

ROCKVILLE, Md. and SUZHOU, China, March 5, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology an...

2024-03-05 13:35 1600

First Patient Treated in Phase 2 GvHD Trial

MELBOURNE, Australia, March 5, 2024 /PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, confirms that the first patient has been enrolled and treated in its Phase 2 clinical trial ofCYP-001...

2024-03-05 10:08 1340

Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform

MELBOURNE, Australia, March 5, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc. (ARTMS), its advanced cyclotron-based isotope production platform, manuf...

2024-03-05 07:01 1337

Optimum Nutrition Launches New Global Marketing Campaign "Unlock More You"

The campaign taps into the universal human desire to unlock more within ourselves, regardless of athletic ability or achievement DUBLIN, March 4, 2024 /PRNewswire/ -- Optimum Nutrition, the world's #1 sports nutrition brand1 from Glanbia Performance Nutrition (GPN), today releases its new global...

2024-03-04 22:00 2072

Cyient Partners with MassMedic to Accelerate MedTech Innovation

HYDERABAD, India, March 4, 2024 /PRNewswire/ -- Cyient, a global Intelligent Engineering and Technology Solutions company, is thrilled to announce its membership with the Massachusetts Medical Device Industry Council (MassMedic), the largest regional MedTech association inthe United States. This ...

2024-03-04 22:00 1125

Henlius Forecasts Profit in 2023: Achieving first full year of profitability, and ushering in a new phase of high-quality development

SHANGHAI, March 4, 2024 /PRNewswire/ -- Henlius (2696.HK) released a positive profit forecast. Based on the preliminary assessment of the unaudited consolidated management accounts for the year ended31 December, 2023 (the "Reporting Period") and the information currently available to the Board,it...

2024-03-04 21:19 1730

Milliken & Company Recognized Among the 2024 World's Most Ethical Companies®

SPARTANBURG, S.C., March 4, 2024 /PRNewswire/ -- Diversified global manufacturer Milliken & Company is proud to be included on the 2024 World's Most Ethical Companies list curated by Ethisphere, a leader in defining and advancing the standards of ethical business practices. This annual recognition...

2024-03-04 21:00 995

Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management

MANCHESTER, England, March 4, 2024 /PRNewswire/ -- Phagenesis, a pioneering UK company which has developed a revolutionary neurostimulation system to treat swallowing dysfunction, has closed a$42M Series D financing all equity investment round. The combined European andUnited States investment sy...

2024-03-04 20:00 875

Hybribio Calls for Raising International HPV Awareness

GUANGZHOU, China, March 4, 2024 /PRNewswire/ -- March 4th 2024 marks the 7th International HPV Awareness Day, a global campaign proposed by the International Papillomavirus Society (IPVS) since 2018. This year, the theme is One Less Worry. On this special day, Hybribio (300639.SZ) calls for raisi...

2024-03-04 18:47 1394

Results from the Clinical Trial of Qilu Pharmaceutical's Novel Anticancer Agent Iparomlimab and Tuvonralimab (QL1706) Featured in Oral Presentation at the ESGO Annual Meeting

JINAN, China, March 4, 2024 /PRNewswire/ -- The European Society of Gynecological Oncology (ESGO) 2024 Conference has recently made selected abstracts available online. The abstract (abstract # 251) that details results from the Phase II clinical trial (DUBHE-C-206) evaluating the efficacy and s...

2024-03-04 16:53 1319

Caliway Announced Orphan Drug Designation Granted to CBL-514 for the Treatment of Dercum's Disease

* CBL-514 is the first and only drug to receive both Orphan Drug Designation and Fast Track designation for Dercum's disease treatment. NEW TAIPEI CITY, March 4, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announced that the U.S. Food and Drug Administration (FDA) granted Orphan D...

2024-03-04 16:22 1134

THAILAND EXPECTS 25% GROWTH IN FITNESS AND MASS PARTICIPATION SPORTS FOR 2024

BASE Bangkok 'Asia's Gym of the Year' Partners with Hyrox Fitness Race to Further  Elevate Physical Training inSoutheast Asia BANGKOK, March 4, 2024 /PRNewswire/ -- According to the Thai Mass Participation Sports Trade Association (TMPSA) over 1,500 mass participation sports such as marathons, ...

2024-03-04 09:00 2282

Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children's Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2

FORT LEE, N.J., March 2, 2024 /PRNewswire/ -- Mezzion Pharmaceuticals is a rare disease company conducting the confirmatory pivotal phase 3 clinical trial in Fontan subjects: The Fontan Udenafil Exercise Longitudinal Assessment Trial- 2, or FUEL-2 trial. The company is pleased to announce Dr.Rahu...

2024-03-02 10:26 2823

The 16th Zhang Zhongjing Medicine Culture Festival & Forum on High-quality Development of TCM Takes Place in Nanyang, China

NANYANG, China, March 2, 2024 /PRNewswire/ -- Co-hosted by the Nanyang Chinese Medicine Development Bureau, the China Association of Chinese Medicine (CACM) and the China Association of Traditional Chinese Medicine (CATCM), the Zhang Zhongjing Medicine Culture Festival & Forum on High-quality Dev...

2024-03-02 05:10 2997

LIFE FITNESS ANNOUNCES PROMOTION OF ANDREW MAHADEVAN TO CHIEF COMMERCIAL OFFICER TO LEAD CONTINUED GROWTH

ROSEMONT, Ill., March 2, 2024 /PRNewswire/ -- Life Fitness, the global leader in commercial fitness equipment, is pleased to announce the promotion ofAndrew Mahadevan, Vice President & Managing Director, to Chief Commercial Officer, effectiveApril 1. Mr. Mahadevan's announcement follows the retir...

2024-03-02 02:00 2427

Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories

* Kinnate has entered into an Asset Purchase Agreement (the "APA") with Pierre Fabre Laboratories for global rights to exarafenib and other pan-RAF program assets. * The transaction is in furtherance of Kinnate's previously announced pursuit of strategic alternatives. * This acquisition is ...

2024-03-01 21:35 3539

Thermo Fisher Scientific to Inaugurate New Office, Marking Milestone Expansion in Indonesia

Company to support advancements in country's science and technology sector, with a focus on progressing healthcare, environmental solutions, and food safety JAKARTA, Indonesia, March. 1, 2024 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, will significantly expand ...

2024-03-01 10:30 9560
1 ... 6789101112 ... 551

Week's Top Stories